Awarepoint Announces Independent Clinical Testing of Its T2S Real-Time Location System (RTLS) Tag
May 29th, 2009
PR-CANADA: Awarepoint Corporation, a provider of ZigBee-based real-time location systems (RTLS) for hospitals, today announced it has completed independent clinical testing for its T2S sterilizable RTLS tag. Independent testing has been performed by SPSmedical for decontamination and mechanical cleaning, Cytotoxicity, steam pre-vacuum efficacy, and STERRAD® Sterilization Systems including use in wrapped trays and Tyvek® Peel Pouches. Awarepoint chose SPSmedical because they are the largest sterilizer testing laboratory in North America. SPSmedical subjected Awarepoint's T2S RTLS tag to product-specific cleaning, sterilization and disinfection procedures for reusable devices, including:
1 Decontamination and Mechanical Cleaning
This validates the effectiveness of decontamination and cleaning process when the tag is subjected to a mechanical washer.
2 Cytotoxicity
Samples from the tested Awarepoint T2S Tag met the USP and ISO 10993-5 requirements and are considered non-toxic under the test conditions employed.
3 Pre-vacuum Steam Sterilization Study
Performance testing validated the recommended cycle parameters are safe and effective when sterilizing the Awarepoint T2S sterilizable Tag per AAMI/ISO guidelines.
4 STERRAD® Sterilization Systems
Performance testing confirms the recommended cycle parameters are safe and effective for use when sterilizing the Awarepoint T2S sterilizable Tags in a hospital STERRAD® 100S sterilization full cycle. The protocol for STERRAD® testing included use in the wrapped tray and Tyvek® Peel Pouch.
All original reports are on file at Awarepoint's corporate office in San Diego, California.
Click here for complete story from PR-CANADA
Categories: Access Control, Asset Tracking, Healthcare, News